Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK : A Nested Case–Control and Case‐Crossover Study

Documenti analoghi

• Validation of Immune‐Related Adverse Event (irAE) Case Definitions in a Real‐World Lung Cancer Population
  di: James S. Heyward, et al.
  Pubblicazione: (2025)
• A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database
  di: Le Hai, et al.
  Pubblicazione: (2024)
• Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
  di: W. N. Kelly, et al.
  Pubblicazione: (2024)
• A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid
  di: Le Hai, et al.
  Pubblicazione: (2025)
• Assessing Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Incidence of Major Adverse Cardiovascular Events: A Retrospective Cohort Study
  di: Aljoharah M. Algabbani, et al.
  Pubblicazione: (2025)